BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38215561)

  • 1. Generation of induced pluripotent stem cell line LNDWCHi001-A from a patient with early-onset Parkinson's disease carrying the homozygous c.1898C > T (p. A633V) mutation in the PLA2G6 gene.
    Huang J; Jiang Q; Pang D; Yu Y; Cui Y; Li C; Shang H
    Stem Cell Res; 2024 Mar; 75():103305. PubMed ID: 38215561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of feeder-independent transgene-free iPSC lines from a young-onset Parkinson's disease (YOPD) patient with a homozygous PLA2G6: c.2222G>A (p. Arg741Gln) mutation (NCBSi003-A) and unaffected heterozygous parent (NCBSi004-A).
    Gopurappilly R; Musthafa T; Sukumaran S; Viswanath B; Hasan G
    Stem Cell Res; 2023 Mar; 67():103033. PubMed ID: 36706537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of induced pluripotent stem cells from a young-onset Parkinson's disease patient carrying the compound heterozygous PLA2G6 p.D331Y/p.M358IfsX mutations.
    Chiu CC; Wang HL; Weng YH; Chen RS; Chen CM; Yeh TH; Lu CS; Chen YJ; Liu YC; Huang YZ; Chang KH
    Stem Cell Res; 2019 Oct; 40():101552. PubMed ID: 31493761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene.
    Cheng YC; Lin HI; Syu SH; Lu HE; Huang CY; Lin CH; Hsieh PCH
    Stem Cell Res; 2019 May; 37():101432. PubMed ID: 30978640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLA2G6 mutations in PARK14-linked young-onset parkinsonism and sporadic Parkinson's disease.
    Lu CS; Lai SC; Wu RM; Weng YH; Huang CL; Chen RS; Chang HC; Wu-Chou YH; Yeh TH
    Am J Med Genet B Neuropsychiatr Genet; 2012 Mar; 159B(2):183-91. PubMed ID: 22213678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARK14 (D331Y) PLA2G6 Causes Early-Onset Degeneration of Substantia Nigra Dopaminergic Neurons by Inducing Mitochondrial Dysfunction, ER Stress, Mitophagy Impairment and Transcriptional Dysregulation in a Knockin Mouse Model.
    Chiu CC; Lu CS; Weng YH; Chen YL; Huang YZ; Chen RS; Cheng YC; Huang YC; Liu YC; Lai SC; Lin KJ; Lin YW; Chen YJ; Chen CL; Yeh TH; Wang HL
    Mol Neurobiol; 2019 Jun; 56(6):3835-3853. PubMed ID: 30088174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLA2G6 mutations cause motor dysfunction phenotypes of young-onset dystonia-parkinsonism type 14 and can be relieved by DHA treatment in animal models.
    Yeh TH; Liu HF; Chiu CC; Cheng ML; Huang GJ; Huang YC; Liu YC; Huang YZ; Lu CS; Chen YC; Chen HY; Cheng YC
    Exp Neurol; 2021 Dec; 346():113863. PubMed ID: 34520727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype correlations of adult-onset PLA2G6-associated Neurodegeneration: case series and literature review.
    Chu YT; Lin HY; Chen PL; Lin CH
    BMC Neurol; 2020 Mar; 20(1):101. PubMed ID: 32183746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease.
    Miki Y; Tanji K; Mori F; Kakita A; Takahashi H; Wakabayashi K
    Neurosci Lett; 2017 Apr; 645():40-45. PubMed ID: 28213071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PLA2G6 gene in early-onset Parkinson's disease.
    Kauther KM; Höft C; Rissling I; Oertel WH; Möller JC
    Mov Disord; 2011 Nov; 26(13):2415-7. PubMed ID: 21812034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe early-onset impulsive compulsive behavior and psychosis in PLA2G6-related juvenile Parkinson's disease.
    Wirth T; Weibel S; Montaut S; Bigaut K; Rudolf G; Chelly J; Tranchant C; Anheim M
    Parkinsonism Relat Disord; 2017 Aug; 41():127-129. PubMed ID: 28549837
    [No Abstract]   [Full Text] [Related]  

  • 12. PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort.
    Shi CH; Tang BS; Wang L; Lv ZY; Wang J; Luo LZ; Shen L; Jiang H; Yan XX; Pan Q; Xia K; Guo JF
    Neurology; 2011 Jul; 77(1):75-81. PubMed ID: 21700586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous p.D331Y mutation in PLA2G6 in two patients with pure autosomal-recessive early-onset parkinsonism: further evidence of a fourth phenotype of PLA2G6-associated neurodegeneration.
    Xie F; Cen Z; Ouyang Z; Wu S; Xiao J; Luo W
    Parkinsonism Relat Disord; 2015 Apr; 21(4):420-2. PubMed ID: 25660576
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism.
    Yoshino H; Tomiyama H; Tachibana N; Ogaki K; Li Y; Funayama M; Hashimoto T; Takashima S; Hattori N
    Neurology; 2010 Oct; 75(15):1356-61. PubMed ID: 20938027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human induced pluripotent stem cells line (PNUSCRi004-A) from a Parkinson's disease patient carrying L483P, A495P and V499V mutations.
    Moon HJ; Lee N; Moon JY; Lee JH; Kim JH
    Stem Cell Res; 2023 Apr; 68():103051. PubMed ID: 36805467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of Parkinson's disease patient-derived human induced pluripotent stem cells line (PNUSCRi001-A) carrying a N227S mutation in GBA gene.
    Lee N; Moon HJ; Park SH; Moon JY; Park KK; Kim JH; Lee JH
    Stem Cell Res; 2022 Dec; 65():102959. PubMed ID: 36332465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease.
    Gui YX; Xu ZP; Wen-Lv ; Liu HM; Zhao JJ; Hu XY
    Parkinsonism Relat Disord; 2013 Jan; 19(1):21-6. PubMed ID: 23182313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation screening of PLA2G6 in Japanese patients with early onset dystonia-parkinsonism.
    Yamashita C; Funayama M; Li Y; Yoshino H; Yamada H; Seino Y; Tomiyama H; Hattori N
    J Neural Transm (Vienna); 2017 Apr; 124(4):431-435. PubMed ID: 27942883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of ATP13A2, PLA2G6 and FBXO7 in a cohort of Chinese patients with early-onset Parkinson's disease.
    Shen T; Pu J; Lai HY; Xu L; Si X; Yan Y; Jiang Y; Zhang B
    Sci Rep; 2018 Sep; 8(1):14028. PubMed ID: 30232368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson's disease.
    Zhou Q; Yen A; Rymarczyk G; Asai H; Trengrove C; Aziz N; Kirber MT; Mostoslavsky G; Ikezu T; Wolozin B; Bolotina VM
    Nat Commun; 2016 Jan; 7():10332. PubMed ID: 26755131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.